Heein Song, Sébastien J Dumas, Gangqi Wang, Lijun Ma, Franca Witjas, M Cristina Avramut, Cathelijne W van den Berg, Michael V Rocco, Barry I Freedman, Ton J Rabelink, H Siebe Spijker
{"title":"APOL1风险变异诱导患者源性肾类器官足细胞代谢重编程。","authors":"Heein Song, Sébastien J Dumas, Gangqi Wang, Lijun Ma, Franca Witjas, M Cristina Avramut, Cathelijne W van den Berg, Michael V Rocco, Barry I Freedman, Ton J Rabelink, H Siebe Spijker","doi":"10.1016/j.stemcr.2025.102650","DOIUrl":null,"url":null,"abstract":"<p><p>Carriers of two apolipoprotein L1 gene risk variants (RVs), termed G1 and G2, are at increased risk for chronic kidney disease. This study utilized induced pluripotent stem cells (iPSCs) derived from two patients homozygous for G1 and G2 to model human apolipoprotein L1 (APOL1)-mediated kidney disease (AMKD) in kidney organoids. Single-cell transcriptomic analysis and immunofluorescence imaging showed APOL1 upregulation in podocytes after interferon-gamma (IFN-γ) treatment. Transcriptomics and spatial dynamic metabolomics demonstrated a significant reduction in oxidative phosphorylation and tricarboxylic acid (TCA) cycle activity, along with upregulation of glycolysis and hypoxia signaling in RV podocytes. Isolated RV glomeruli exhibited no increase in maximal respiration rate following IFN-γ treatment, while iPSC-derived RV podocytes displayed a reduced number of mitochondrial branches and shorter branch length. This model presents early metabolic reprogramming of RV podocytes upon inflammatory injury and compelling evidence that mitochondrial dysfunction plays a pivotal role in the early pathophysiology of AMKD.</p>","PeriodicalId":21885,"journal":{"name":"Stem Cell Reports","volume":" ","pages":"102650"},"PeriodicalIF":5.1000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"APOL1 risk variants induce metabolic reprogramming of podocytes in patient-derived kidney organoids.\",\"authors\":\"Heein Song, Sébastien J Dumas, Gangqi Wang, Lijun Ma, Franca Witjas, M Cristina Avramut, Cathelijne W van den Berg, Michael V Rocco, Barry I Freedman, Ton J Rabelink, H Siebe Spijker\",\"doi\":\"10.1016/j.stemcr.2025.102650\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Carriers of two apolipoprotein L1 gene risk variants (RVs), termed G1 and G2, are at increased risk for chronic kidney disease. This study utilized induced pluripotent stem cells (iPSCs) derived from two patients homozygous for G1 and G2 to model human apolipoprotein L1 (APOL1)-mediated kidney disease (AMKD) in kidney organoids. Single-cell transcriptomic analysis and immunofluorescence imaging showed APOL1 upregulation in podocytes after interferon-gamma (IFN-γ) treatment. Transcriptomics and spatial dynamic metabolomics demonstrated a significant reduction in oxidative phosphorylation and tricarboxylic acid (TCA) cycle activity, along with upregulation of glycolysis and hypoxia signaling in RV podocytes. Isolated RV glomeruli exhibited no increase in maximal respiration rate following IFN-γ treatment, while iPSC-derived RV podocytes displayed a reduced number of mitochondrial branches and shorter branch length. This model presents early metabolic reprogramming of RV podocytes upon inflammatory injury and compelling evidence that mitochondrial dysfunction plays a pivotal role in the early pathophysiology of AMKD.</p>\",\"PeriodicalId\":21885,\"journal\":{\"name\":\"Stem Cell Reports\",\"volume\":\" \",\"pages\":\"102650\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-10-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stem Cell Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.stemcr.2025.102650\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CELL & TISSUE ENGINEERING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem Cell Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.stemcr.2025.102650","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
APOL1 risk variants induce metabolic reprogramming of podocytes in patient-derived kidney organoids.
Carriers of two apolipoprotein L1 gene risk variants (RVs), termed G1 and G2, are at increased risk for chronic kidney disease. This study utilized induced pluripotent stem cells (iPSCs) derived from two patients homozygous for G1 and G2 to model human apolipoprotein L1 (APOL1)-mediated kidney disease (AMKD) in kidney organoids. Single-cell transcriptomic analysis and immunofluorescence imaging showed APOL1 upregulation in podocytes after interferon-gamma (IFN-γ) treatment. Transcriptomics and spatial dynamic metabolomics demonstrated a significant reduction in oxidative phosphorylation and tricarboxylic acid (TCA) cycle activity, along with upregulation of glycolysis and hypoxia signaling in RV podocytes. Isolated RV glomeruli exhibited no increase in maximal respiration rate following IFN-γ treatment, while iPSC-derived RV podocytes displayed a reduced number of mitochondrial branches and shorter branch length. This model presents early metabolic reprogramming of RV podocytes upon inflammatory injury and compelling evidence that mitochondrial dysfunction plays a pivotal role in the early pathophysiology of AMKD.
期刊介绍：
Stem Cell Reports publishes high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine. Our particular focus on shorter, single-point articles, timely publication, strong editorial decision-making and scientific input by leaders in the field and a "scoop protection" mechanism are reasons to submit your best papers.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
